Page 2 - Given Maxcyte News Today

MaxCyte (NASDAQ:MXCT – Get Rating) is one of 39 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its peers? We will compare MaxCyte to related companies based on the strength of its analyst recommendations, earnings, dividends, institutional ownership, profitability, valuation and risk. Analyst Ratings This is a […]

MaxCyte (NASDAQ:MXCT – Get Rating) is one of 39 public companies in the “Commercial physical research” industry, but how does it contrast to its competitors? We will compare MaxCyte to similar companies based on the strength of its analyst recommendations, valuation, profitability, risk, earnings, dividends and institutional ownership. Profitability This table compares MaxCyte and its […]

MaxCyte (NASDAQ:MXCT – Get Rating) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it contrast to its rivals? We will compare MaxCyte to similar companies based on the strength of its valuation, institutional ownership, dividends, profitability, risk, earnings and analyst recommendations. Institutional & Insider Ownership 65.9% of MaxCyte […]

MaxCyte (NASDAQ:MXCT – Get Rating) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it contrast to its peers? We will compare MaxCyte to related companies based on the strength of its risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Valuation & Earnings This table compares MaxCyte […]

MaxCyte (NASDAQ:MXCT – Get Rating) is one of 39 public companies in the “Commercial physical research” industry, but how does it contrast to its competitors? We will compare MaxCyte to similar businesses based on the strength of its dividends, analyst recommendations, risk, profitability, earnings, institutional ownership and valuation. Analyst Recommendations This is a breakdown of […]

MaxCyte (NASDAQ:MXCT – Get Rating) is one of 39 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its rivals? We will compare MaxCyte to related businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings. Analyst Ratings This is a […]

MaxCyte (NASDAQ:MXCT – Get Rating) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it compare to its competitors? We will compare MaxCyte to related businesses based on the strength of its risk, dividends, valuation, profitability, earnings, analyst recommendations and institutional ownership. Profitability This table compares MaxCyte and its […]

MaxCyte (NASDAQ:MXCT – Get Rating) is one of 39 public companies in the “Commercial physical research” industry, but how does it compare to its peers? We will compare MaxCyte to similar companies based on the strength of its earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and dividends. Analyst Recommendations This is a summary of […]